Thermo Fisher and Charles River join Multiply Labs’ robotic consortium

By The Science Advisory Board staff writers

May 9, 2022 -- Multiply Labs has added Thermo Fisher Scientific and Charles River Laboratories to its robotic cell therapy manufacturing consortium, joining Cytiva and the University of California, San Francisco (UCSF) as members. This consortium promotes the automation and advancement of cell therapy manufacturing technologies.

A major purpose of Multiply Labs' consortium is to reduce the time and cost associated with the manual labor demands linked with cell therapy manufacturing. By automating these processes with robotic technologies and innovations, the consortium supports more efficient generation of cell therapies to provide patients with access to them sooner. As a result, the consortium demonstrates the beneficial capabilities of robotic integration into the drug manufacturing process.

Multiply Labs coordinates activities in the consortium related to robotics development, while UCSF is tasked with leading the cell manufacturing process as part of a research agreement. Regarding the roles of other consortium members, Cytiva uses its specialized bioreactor technology to manufacture CAR T-cell therapies. As new additions, Thermo Fisher will guide the automated operation of incubators and Charles River will focus on automating the quality control testing required as part of the manufacturing process. These institutions will all work toward the common goal of bringing these gene modified cell therapies to patients more quickly with the advantage of robotic technology.

Charles River, Valo Health create AI drug software
Charles River Laboratories and Valo Health have launched Logica, an artificial intelligence (AI) powered drug discovery software application that creates...
Portal Innovations partners with Thermo Fisher company
Portal Innovations is collaborating with Life Technologies, part of Thermo Fisher Scientific, to combine Life Technologies’ lab equipment and software...
Thermo Fisher receives accolades for contract manufacturing leadership
For the third consecutive year, Thermo Fisher Scientific’s pharma and biotech customers have recognized its contract manufacturing leadership in all six...
Charles River expands strategic partnership with SAMDI Tech
Charles River Laboratories has expanded its strategic partnership with SAMDI Tech. The expanded agreement will provide Charles River's clients seamless...
Multiply Labs raises $20M to pioneer robotic manufacturing
Multiply Labs has received $20 million in investments to pioneer the robotic manufacturing of individualized drugs.

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter